Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice

Scott, 1987, Long-term outcome of treating rheumatoid arthritis: results after 20 years, Lancet, 1, 1108, 10.1016/S0140-6736(87)91672-2 2002, Guidelines for the management of rheumatoid arthritis: 2002 Update, Arthritis Rheum, 46, 328, 10.1002/art.10148 Gonzalez-Alvaro, 2002, Variations in the drug treatment of rheumatoid arthritis in Spain, Med Clin (Barc), 118, 771 Cush, 1990, Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis, Arthritis Rheum, 33, 19, 10.1002/art.1780330103 Olsen, 1988, In vitro rheumatoid factor synthesis in patients taking second-line drugs for rheumatoid arthritis. Independent associations with disease activity, Arthritis Rheum, 31, 1090, 10.1002/art.1780310902 Díaz-González, 1998, Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs, Immunol Today, 19, 169, 10.1016/S0167-5699(97)01216-4 Dominguez-Jimenez, 1999, Prevention of alphaII(b)beta3 activation by non-steroidal antiinflammatory drugs, FEBS Lett, 446, 318, 10.1016/S0014-5793(99)00236-7 Kopp, 1994, Inhibition of NF-kappa B by sodium salicylate and aspirin, Science, 265, 956, 10.1126/science.8052854 Singh, 1998, Recent considerations in nonsteroidal anti-inflammatory drug gastropathy, Am J Med, 105, 31, 10.1016/S0002-9343(98)00072-2 Wolfe, 1999, Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs, N Engl J Med, 340, 1888, 10.1056/NEJM199906173402407 Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group, N Engl J Med, 343, 1520, 10.1056/NEJM200011233432103 Chan, 2002, Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis, N Engl J Med, 347, 2104, 10.1056/NEJMoa021907 Psaty, 2005, COX-2 inhibitors--lessons in drug safety, N Engl J Med, 352, 1133, 10.1056/NEJMe058042 Strand, 2002, The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors, Arthritis Rheum, 47, 349, 10.1002/art.10560 Balsa, 2004, Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis, J Rheumatol, 31, 40 Gonzalez-Alvaro, 2003, Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis, J Rheumatol, 30, 697 Carmona, 2003, Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity, Ann Rheum Dis, 62, 897, 10.1136/ard.62.9.897 Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 Esteve-Vives, 1993, Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency. Grupo para la Adaptacion del HAQ a la Poblacion Espanola, J Rheumatol., 20, 2116 Alonso, 1995, The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results, Med Clin (Barc), 104, 771 Prevoo, 1995, Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, 38, 44, 10.1002/art.1780380107 Edmonds, 1999, Introduction to reading radiographs by the Scott modification of the Larsen method, J Rheumatol, 26, 740 Baum, 1985, Utilization of nonsteroidal antiinflammatory drugs, Arthritis Rheum, 28, 686, 10.1002/art.1780280613 Hamerman, 1995, Clinical implications of osteoarthritis and ageing, Ann Rheum Dis, 54, 82, 10.1136/ard.54.2.82 Justice, 2005, Cardiovascular risk and COX-2 inhibition in rheumatological practice, J Hum Hypertens, 19, 1, 10.1038/sj.jhh.1001777 Isomaki, 1984, Comparison of the analgesic effect of ten nonsteroidal anti-inflammatory drugs, Br J Rheumatol, 23, 61, 10.1093/rheumatology/23.1.61 Johnson, 1994, Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis, Ann Intern Med, 121, 289, 10.7326/0003-4819-121-4-199408150-00011 Solomon, 2003, Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis, Circulation, 107, 1303, 10.1161/01.CIR.0000054612.26458.B2 Laine, 1999, A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group, Gastroenterology, 117, 776, 10.1016/S0016-5085(99)70334-3 Mamdani, 2004, Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study, BMJ, 328, 1415, 10.1136/bmj.38068.716262.F7 Laine, 2001, Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient, Gastroenterology, 120, 594, 10.1053/gast.2001.21907